Heska Corp
HSKADelisted Jun 13, 2023- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001038133
Heska Corp was delisted on Jun 13, 2023; its insiders filed their last Form 4 on Jun 14, 2023; 152 institutions reported holding it in 13F filings for Q1 2023, worth $1.01B in total; no superinvestor held it.
13F holders, Q2 2023
Institutional positions in Heska Corp as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
HSKA is no longer listed, and 13F filings after Q1 2023 list far fewer holders. See Q1 2023
- Institutional holders
- 4
- −148 vs. Q1 2023
- Shares held
- 11.2K
- −10.3M (−99.9%) vs. Q1 2023
- Total value
- $1.14M
- −$1.01B (−99.9%) vs. Q1 2023
- New holders
- 2
- 0 more added
- Sold out
- 150
- 0 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HSKA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 4 | $1.14M |
| Q1 2023 | 152 | $1.01B |
| Q4 2022 | 154 | $649.1M |
| Q3 2022 | 167 | $781.2M |
| Q2 2022 | 169 | $993.1M |
| Q1 2022 | 170 | $1.44B |
| Q4 2021 | 185 | $1.89B |
| Q3 2021 | 195 | $2.62B |
| Q2 2021 | 182 | $2.32B |
| Q1 2021 | 186 | $1.67B |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Heska Corp; share changes are against Q1 2023.